Edwards Lifesciences从Baxter公司拆分出来,在纽约证券交易所(NYSE)进行交易 EW 2000 位于多米尼加共和国海纳(Haina)的制造厂隆重开幕 2004 Edwards收购了经皮瓣膜技术有限公司(Percutaneous Valve Technologies) 2005 增加了FloTrac微创血流动力学监护业务 2007
*Edwards Lifesciences Critical Care is now part of BD (Becton, Dickinson and Company) Patients We are dedicated to providing innovative solutions for people fighting cardiovascular disease More about us Clinical research information Clinical research means new hope for others ...
Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.
Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to ...
Welcome to Edwards Lifesciences Grant Portal To get started, please click on your geographic region: + −Contact us Legal terms Privacy policy Consumer Health Data Privacy Policy Your Privacy Choices © 2025 Edwards Lifesciences Corporation. All rights reserved. Cookie Settings ...
Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.
Edwards Lifesciences - CenteraUlrich Schäfer
Edwards Lifesciences Room 310, 3F, Tower B, 21st Century Building No. 40A, Liangmaqiao Road, Chao Yang District Beijing 100125, China 电话86.10.5641.0888 新加坡 亚太总部 Edwards Lifesciences (Asia) Pte Ltd 51 Changi Business Park Central 2 ...
Edwards Lifesciences预计2025年将实现稳定增长EW 0.46% 纽约- 结构性心脏创新领域的领导者Edwards Lifesciences Corporation(纽约证券交易所代码:EW),市值414亿美元,今天在其年度投资者大会上概述了其强劲增长战略并更新了技术管线。根据InvestingPro分析,该公司目前的估值相对于其近期盈利增长潜力来说具有吸引力。该公司...